How does A001067's PE Ratio compare to its peers?

A001067 is good value based on its Price-To-Earnings Ratio (7.9x) compared to the peer average (10.4x).

How does A001067's PE Ratio compare vs other companies in the KR Pharmaceuticals Industry?

A001067 is good value based on its Price-To-Earnings Ratio (7.9x) compared to the KR Pharmaceuticals industry average (11.4x).

What is A001067's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A001067 is good value based on its Price-To-Earnings Ratio (7.9x) compared to the estimated Fair Price-To-Earnings Ratio (17.2x).

What is the Fair Price of A001067 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

A001067 (₩62300) is trading below our estimate of [[fair value]] (₩243820.68)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

JW Pharmaceutical (KOSE:A001067) - Stock Price, News & Analysis

A001067 Stock Overview

Manufactures and sells medicines and medical supplies in Japan and internationally. More details

A001067 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	6/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 74.4% below our estimate of its fair value

Earnings are forecast to grow 13.31% per year

Earnings grew by 190.7% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Shareholders have been diluted in the past year

JW Pharmaceutical Corporation Competitors

Dong-A Socio Holdings

KOSE:A000640

₩653.2b

DongKook Pharmaceutical

KOSDAQ:A086450

₩737.8b

Boryung

KOSE:A003850

₩678.4b

Daewoong

KOSE:A003090

₩871.0b

Price History & Performance

Summary of all time highs, changes and price drops for JW Pharmaceutical
Historical stock prices
Current Share Price	₩62,300.00
52 Week High	₩62,843.14
52 Week Low	₩53,200.00
Beta	0.51
11 Month Change	5.95%
3 Month Change	8.35%
1 Year Change	0.072%
33 Year Change	16.84%
5 Year Change	40.79%
Change since IPO	247.27%

Recent updates

Shareholder Returns

	A001067	KR Pharmaceuticals	KR Market
7D	0.8%	-1.4%	1.9%
1Y	0.07%	5.3%	-2.6%

Return vs Industry: A001067 underperformed the KR Pharmaceuticals industry which returned 5.3% over the past year.

Return vs Market: A001067 exceeded the KR Market which returned -2.6% over the past year.

Price Volatility

Is A001067's price volatile compared to industry and market?
A001067 volatility
A001067 Average Weekly Movement	3.5%
Pharmaceuticals Industry Average Movement	5.2%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A001067 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A001067's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1945	n/a	Young-Sub Shin	www.jw-pharma.co.kr

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.

JW Pharmaceutical Corporation Fundamentals Summary

How do JW Pharmaceutical's earnings and revenue compare to its market cap?
A001067 fundamental statistics
Market cap	₩589.98b
Earnings (TTM)	₩72.89b
Revenue (TTM)	₩736.54b

7.9x

P/E Ratio

0.8x

P/S Ratio

Is A001067 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A001067 income statement (TTM)
Revenue	₩736.54b
Cost of Revenue	₩401.81b
Gross Profit	₩334.74b
Other Expenses	₩261.84b
Earnings	₩72.89b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.96k
Gross Margin	45.45%
Net Profit Margin	9.90%
Debt/Equity Ratio	35.9%

How did A001067 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

13%

Payout Ratio

Does A001067 pay a reliable dividends?

See A001067 dividend history and benchmarks

When do you need to buy A001067 by to receive an upcoming dividend?
JW Pharmaceutical dividend dates
Ex Dividend Date	Dec 27 2024
Dividend Pay Date	Apr 28 2025
Days until Ex dividend	29 days
Days until Dividend pay date	151 days